Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.

Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.

Ebolaviruses cause an often rapidly fatal syndrome known as Ebola virus disease (EVD), with average case fatality rates of ~50%. There is no licensed vaccine or treatment for EVD, underscoring the urgent need to develop new anti-ebolavirus agents, especially in the face of an ongoing outbreak in the...

Full description

Bibliographic Details
Main Authors:	Evelyn M Covés-Datson, Julie Dyall, Lisa Evans DeWald, Steven R King, Derek Dube, Maureen Legendre, Elizabeth Nelson, Kelly C Drews, Robin Gross, Dawn M Gerhardt, Lisa Torzewski, Elena Postnikova, Janie Y Liang, Bhupal Ban, Jagathpala Shetty, Lisa E Hensley, Peter B Jahrling, Gene G Olinger, Judith M White, David M Markovitz
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-07-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://doi.org/10.1371/journal.pntd.0007595

Similar Items

Lack of Effect of Lamivudine on Ebola Virus Replication
by: Lisa Hensley, et al.
Published: (2015-03-01)

High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona
by: Anna N. Honko, et al.
Published: (2017-07-01)

Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo
by: Courtney L. Finch, et al.
Published: (2021-03-01)

Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors.
by: Matthew Brudner, et al.
Published: (2013-01-01)

Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection
by: Emily Speranza, et al.
Published: (2020-06-01)

Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.
by: Yu Cong, et al.
Published: (2016-01-01)

Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs.
by: Elena Postnikova, et al.
Published: (2018-01-01)

Targeted disruption of pi–pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity
by: Evelyn M. Covés-Datson, et al.
Published: (2021-01-01)

Optimization of Methods for the Production and Refolding of Biologically Active Disulfide Bond-Rich Antibody Fragments in Microbial Hosts
by: Bhupal Ban, et al.
Published: (2020-08-01)

Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples.
by: Elena N Postnikova, et al.
Published: (2019-01-01)

Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection.
by: Charles J Shoemaker, et al.
Published: (2013-01-01)

Correction: Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection
by: Charles J. Shoemaker, et al.
Published: (2013-01-01)

Correction: Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection.
by: Charles J. Shoemaker, et al.
Published: (2013-01-01)

Heparan sulfate is an important mediator of Ebola virus infection in polarized epithelial cells
by: Manasi Tamhankar, et al.
Published: (2018-08-01)

Effective post-exposure treatment of Ebola infection.
by: Heinz Feldmann, et al.
Published: (2007-01-01)

The functional characterisation of the C-type lectin : Clecsf8
by: Graham, Lisa Maria
Published: (2015)

Ebola Virus Isolation Using Huh-7 Cells has Methodological Advantages and Similar Sensitivity to Isolation Using Other Cell Types and Suckling BALB/c Laboratory Mice
by: James Logue, et al.
Published: (2019-02-01)

The temporal program of peripheral blood gene expression in the response of non-human primates to Ebola hemorrhagic fever
by: Rubins, Kathleen H., et al.
Published: (2010)

Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates.
by: Thomas W Geisbert, et al.
Published: (2008-11-01)

A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures
by: Ryan P. Bennett, et al.
Published: (2021-12-01)

Fighting Ebola through Novel Spore Decontamination Technologies for the Military
by: Christopher J. Doona, et al.
Published: (2015-08-01)

Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection.
by: Xiangguo Qiu, et al.
Published: (2012-01-01)

Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model
by: Richard S. Bennett, et al.
Published: (2020-07-01)

The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection.
by: Elizabeth A Nelson, et al.
Published: (2017-04-01)

Communicating and engaging with crisis-affected people in humanitarian responses: a case study of the Red Cross Ebola response in Liberia
by: Qvarfordt, Lisa
Published: (2016)

The Role of Syk/CARD9-Coupled C-Type Lectin Receptors in Immunity to Mycobacterium tuberculosis Infections
by: Mohlopheni Jackson Marakalala, et al.
Published: (2010-01-01)

Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
by: Thomas W. Geisbert, et al.
Published: (2002-05-01)

Increased Likelihood of Detecting Ebola Virus RNA in Semen by Using Sample Pelleting
by: Courtney M. Bozman, et al.
Published: (2021-04-01)

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.
by: Kelly L Warfield, et al.
Published: (2006-01-01)

Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection.
by: Jeffrey R Kugelman, et al.
Published: (2012-01-01)

The Scholarship of Student Affairs Professionals: Effective Writing Strategies and Scholarly Identity Formation Explored through a Coaching Model
by: Hatfield, Lisa Janie
Published: (2015)

Ebola and Its Control in Liberia, 2014–2015
by: Tolbert G. Nyenswah, et al.
Published: (2016-02-01)

LECTINS IN ANTI-CANCER STRATEGIES
by: M. V. Lakhtin, et al.
Published: (2018-07-01)

Potential Vaccines and Post-Exposure Treatments for Filovirus Infections
by: Gene G. Olinger, et al.
Published: (2012-09-01)

Local (intestinal) and systemic responses of animals to ingested Phaseolus vulgaris lectins : mechanism of lectin toxicity
by: Greer, F. M.
Published: (1983)

Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model
by: Timothy K. Cooper, et al.
Published: (2018-01-01)

Can Plant Lectins Help to Elucidate Insect Lectin-Mediated Immune Response?
by: Pengyu Chen, et al.
Published: (2021-05-01)

Recombinant banana lectin as mucosal immunostimulator
by: R. Dimitrijevic, et al.
Published: (2012-07-01)

Ebola Crisis in the United States
by: Avinash Raghunath Patwardhan M.D.
Published: (2014-12-01)

EBOLA
by: Tadeja Kotar
Published: (2014-12-01)